APAC Resources Limited, an investment holding company, engages in resource investment, commodity, and financial service businesses in Hong Kong, the People's Republic of China, Australia, and the Philippines. The company operates through Commodity Business, Resource Investment, and Principal Investment and Financial Services segments. It trades and invests in listed and unlisted securities of energy and natural resources companies, as well as engages in trading commodity activities. In addition, the company provides loan financing and money lending services; and invest in loan notes and other financial assets, and invests in and develops mineral resources. Further, it is involved in provision of consultancy services in corporate management, as well as management and metallurgy technology services. APAC Resources Limited is headquartered in Wan Chai, Hong Kong. Address: Allied Kajima Building, Wan Chai, Hong Kong
Enviro Energy International Holdings Limited, an investment holding company, trades in building materials in the People's Republic of China and Hong Kong. It operates through Sale of Materials Businesses and Properties Investment segments. The company sells aluminum, steel products, timber logs, base metals, and scrapped copper that are primarily used at the early stages of construction projects or for manufacturing of building or surfacing materials. It also engages in properties investment activities. The company was founded in 2000 and is headquartered in Sheung Wan, Hong Kong. Address: No. 9 Des Voeux Road West, Sheung Wan, Hong Kong
China Huarong Energy Company Limited, an investment holding company, engages in the energy exploration and production businesses. It operates through two segments, Energy Exploration and Production; and Oil Storage and Trading. The company explores for, produces, and sells crude oil and sells petroleum products. It is also involved in commodity trading business; and oil and gas trading, wholesale and distribution activities, as well as provision of oil storage services. The company was formerly known as China Rongsheng Heavy Industries Group Holdings Limited and changed its name to China Huarong Energy Company Limited in April 2015. China Huarong Energy Company Limited was founded in 2004 and is headquartered in Chai Wan, Hong Kong. Address: Cornell Centre, Chai Wan, Hong Kong
Mainland Headwear Holdings Limited, an investment holding company, designs, manufactures, trades in, and distributes casual headwear products in the United States, Europe, the People's Republic of China, Hong Kong, and internationally. The company operates through Manufacturing Business and Trading Business segments. It also engages in the trading and distribution of headwear, apparel, small leather goods, bags, and accessories; property holding; provision of research and development, quality control, and administrative, as well as digitizing services; and e-commerce business. Mainland Headwear Holdings Limited was founded in 1986 and is based in Kowloon Bay, Hong Kong. Address: CTF Life Tower, Kowloon Bay, Hong Kong
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. Address: Sinopharm Group Building, Shanghai, China, 200023
Road King Infrastructure Limited, an investment holding company, invests in, develops, operates, and manages property projects and toll roads in the People's Republic of China. It operates through Property Development and Investment, Toll Road, and Investment and Asset Management segments. The company engages in the development, rental, and sale of residential and commercial properties. It also engages in the property funds, cultural, tourist, and commercial businesses. In addition, it provides financial and management services. Further, the company invests in and operates a toll road portfolio of four expressways in Mainland China and four expressways in Indonesia spanning approximately 610 kilometers. As of December 31, 2023, it had a land reserve of approximately 3,570,000 square meters primarily located in Mainland China and Hong Kong. Road King Infrastructure Limited was founded in 1994 and is based in Tsim Sha Tsui, Hong Kong. Address: Tower 6, The Gateway, Tsim Sha Tsui, Hong Kong
i-CABLE Communications Limited, an investment holding company, provides integrated communications services in Hong Kong. The company operates through Media and Telecommunications segments. The Media segment offers television subscription, domestic free television program, advertising, television relay, program licensing, theatrical release, and other related services. Its Telecommunications segment includes operations related to broadband internet access, portal operations, telephony, network leasing, network construction, mobile agency services, and other related businesses. The company also owns and operates wireline telecommunications network, which provides media and telecommunications services to approximately two million households. In addition, it produces television and multimedia content focusing on news, information, sports, and entertainment. Further, the company is involved in property leasing; TV channel and network operation; technology services; installation and maintenance of satellite television systems; musical works production and licensing; agency services; film production, distribution, and licensing services; and technical services. i-CABLE Communications Limited was incorporated in 1999 and is based in Tsuen Wan, Hong Kong. Address: CABLE TV Tower, Tsuen Wan, Hong Kong
Cherish Sunshine International Limited, an investment holding company, trades in various products in the People's Republic of China. It operates through four segments: Provision of Procurement Services and Other IT Services; Trading Business; Rental Income; and Energy Management Contracting Business. The company is involved in the provision of procurement services to governmental authorities, and private enterprises; development of software and provision of maintenance services; provision of engineering, procurement, and construction (EPC) services; and procurement of goods for EPC services. It also engages in the leasing of investment properties; trading of general goods; and provision of energy management contracting services. The company was formerly known as China Public Procurement Limited and changed its name to Cherish Sunshine International Limited in August 2022. Cherish Sunshine International Limited was incorporated in 2001 and is headquartered in Hangzhou, Hong Kong. Address: Block 1, Hangzhou, China
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer. The company also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, it provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food and glucose products; and healthcare services. The company has a strategic partnership with Pfizer Inc. to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China. Address: No. 226 Huanghe Street, Shijiazhuang, China, 050035
South Manganese Investment Limited, an investment holding company, engages in manganese mining, ore processing, and downstream processing operations in Mainland China, Asia, Europe, and North America. It operates through four segments: Manganese Mining, EMM and Alloying Materials Production, Battery Materials Production, and Other Business. The Manganese Mining segment mines and produces manganese products, including manganese concentrate, and natural discharging manganese powder and sand. Its EMM and Alloying Materials segment mines and processes ores used in hydrometallurgical processing activities for the production of electrolytic manganese metal (EMM) and manganese briquette, and pyrometallurgical processing for the production of silicomanganese alloys and ferromanganese. The Battery Materials segment manufactures and sells battery materials products, including Electrolytic Manganese Dioxide (EMD), manganese sulfate, lithium manganese oxide, and lithium nickel cobalt manganese oxide. Its Other Business segment trades in various commodities, such as manganese ores, EMM, manganese alloys, and non-manganese metals, as well as sells scraps, rents investment properties and leasehold lands, and invests in companies engaged in the mining, production, and trading of non-manganese metals. It also manufactures and sells equipment, develops properties, and produces sulphuric acid and steam. The company was formerly known as CITIC Dameng Holdings Limited and changed its name to South Manganese Investment Limited in February 2021. South Manganese Investment Limited was incorporated in 2005 and is headquartered in Admiralty, Hong Kong. Address: United Centre, Room A02, Admiralty, Hong Kong